创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Introduction to the In Vitro Killing Platform

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-12 15:00
  • Views:

(Summary description)InnoModels Biotechnology has always been committed to driving innovation in the life sciences, and its in vitro killing platform is one of the company's major achievements in life sciences research and drug discovery. The platform provides researchers with a highly controllable and precise experimental environment, enabling in vitro cell killing experiments to be conducted more efficiently and reliably, and providing powerful support for new drug screening and drug mechanism research.

InnoModels Biotechnology: Introduction to the In Vitro Killing Platform

(Summary description)InnoModels Biotechnology has always been committed to driving innovation in the life sciences, and its in vitro killing platform is one of the company's major achievements in life sciences research and drug discovery. The platform provides researchers with a highly controllable and precise experimental environment, enabling in vitro cell killing experiments to be conducted more efficiently and reliably, and providing powerful support for new drug screening and drug mechanism research.

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-12 15:00
  • Views:
Information

InnoModels Biotechnology has always been committed to driving innovation in the life sciences, and its in vitro killing platform is one of the company's major achievements in life sciences research and drug discovery. The platform provides researchers with a highly controllable and precise experimental environment, enabling in vitro cell killing experiments to be conducted more efficiently and reliably, and providing powerful support for new drug screening and drug mechanism research.
Definition of in vitro killing platform
In vitro cell killing assays are cell killing experiments performed in an ex vivo environment designed to assess the effects of different factors on cell survival, proliferation and function. Such experimental platforms can provide critical information on potential drug toxicity, therapeutic efficacy and cell survival mechanisms.
Features of InnoModels Bio's in vitro killing assay platforms
InnoModels's in vitro killing platform exhibits unique features in the following areas:
1. Highly controllable experimental conditions:
The platform provides a highly controllable experimental environment, including the regulation of temperature, humidity, atmosphere and other factors, to ensure the accuracy and reproducibility of the experiment.
2. Multiple cell type support:
The platform supports the application of multiple cell types, including tumour cells, primary cells, etc., enabling researchers to carry out a wide range of studies in different fields.
3. real-time monitoring and data recording:
During the experiment, the platform can monitor the cell status and response in real time, and at the same time carry out data recording and analysis, providing researchers with comprehensive experimental results.
4. use of automation technology:
With the use of advanced automation technology, the experimental process is more efficient, reducing experimental errors and improving the reliability of the experiment.

 


Application fields
The in vitro killing experimental platform of InnoModels Biotechnology is widely used in the following fields:
Drug screening and evaluation:
Researchers can use the platform to conduct large-scale drug screening and evaluate the killing effect of drugs on cells.
Toxicity testing:
Used to assess the toxicity level of compounds or drugs, providing important data for safety assessment during drug development.
Immunotherapy Research:
The platform can be used to assess the killing effect of immune cells on tumour cells when studying immunotherapy.
Conclusion
The in vitro killing assay platform from InnoModels Biotechnology provides researchers with an advanced and efficient tool to facilitate the development and application of cell killing assays. With highly controllable experimental conditions and the support of multiple cell types, the platform provides a reliable experimental platform for drug discovery and life science research, advancing the scientific field.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司